Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours Β· Estimated delivery Aug 28 - Sep 2
Minor side effects can include: A bit of tenderness, puffiness, or pink discoloration right around the puncture A brief warm or flushed sensation Mild headache or nausea Reach out to a medical professional right away if you notice: Redness that keeps spreading, heat, or discharge near the site (possible infection) Hives, facial swelling, or difficulty breathing (possible allergic reaction) Persistent numbness or tingling that spreads beyond the site Fever or chills within 48 hours of injection Safe Needle Disposal and Storage A proper FDA-cleared sharps bin is ideal
AOD-9604 Adolescent (12 to 17) Dosing: What Clinicians and Parents Need to Know At a glance Regulatory status / No FDA approval for any indication or age group Typical research dose in adults / 250 to 500 mcg subcutaneous once daily (not validated in adolescents) Adolescent trial evidence / Zero published RCTs in the 12, 17 age group Key safety concern / Potential interference with growth-plate biology and pubertal GH axis Compounding status / Available only through 503A compounding pharmacies under prescriber order Primary preclinical evidence / Heffernan et al
And as it does, a picture is emerging that looks very familiar to practitioners of functional and integrative medicineone defined by viral persistence, mitochondrial dysfunction, chronic inflammation, immune dysregulation, microbiome disruption, and autonomic nervous system damage
As a researcher, partner with a reputable supplier
Ask your healthcare professional about what might be a realistic expectation for you
CJC-1295 acts as a sustained growth hormone-releasing hormone (GHRH) analog, promoting prolonged elevation of both growth hormone and IGF-1
